Option Care Health director sells shares at $31.65
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Option Care Health, Inc. director R. Carter Pate reported two direct sales of common stock: 6,092 shares on November 10, 2026, and 400 shares on November 11, 2026. Both transactions were priced at $31.65 per share. No Rule 10b5-1 plan is reported.
Insider Trade Summary
Net Seller: 6,492 shares
Net Sell
2 txns
Insider
Pate R Carter
Role
Director
Sold
6,492 shs ($205K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 400 | $31.65 | $13K |
| Sale | Common Stock | 6,092 | $31.65 | $193K |
Holdings After Transaction:
Common Stock — 14,128 shares (Direct)
Key Figures
Shares sold: 6,092 shares
Shares sold: 400 shares
Sale price: $31.65 per share
3 metrics
Shares sold
6,092 shares
Direct common-stock sale on November 10, 2026
Shares sold
400 shares
Direct common-stock sale on November 11, 2026
Sale price
$31.65 per share
Both reported sales
Key Terms
Rule 10b5-1
1 terms
Rule 10b5-1 regulatory
"No Rule 10b5-1 plan is reported"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.